Cardiovascular disease remains the leading cause of morbidity and mortality among cancer survivors, according to a correspondence published in Cardio-Oncology. While multiple cardiovascular risk prediction models currently exist to provide risk stratification for patients who are about to undergo cancer treatment, current tools exhibit notable limitations in guiding heart failure management.
Writing in the journal, authors Arianne Clare Agdamag and Wilson Tang report that existing cardiovascular risk models offer limited guidance on how to prevent, modify, and monitor for heart failure. This deficiency is particularly acute regarding heart failure with preserved ejection fraction, or HFpEF, leaving a critical gap in clinical protocols for oncology patients.
The authors explain that cancer survivors face an elevated risk for developing heart failure with preserved ejection fraction due to the development of cardiometabolic syndrome associated with aging and long-term survival.
To overcome these limitations, future efforts should focus on identifying novel biomarkers for assessing heart failure and developing large, multicenter databases capable of validating prediction models across diverse populations. In addition, the authors emphasize the necessity of defining clear treatment pathways once an elevated risk is identified.
Ultimately, the correspondence concludes that a more comprehensive and inclusive risk stratification model, paired with pragmatic approaches to clinical care, will allow for more widespread use among cardiologists and oncologists caring for cancer survivors.
Subject of Research: Heart failure risk prediction models and standardized care pathways in cancer survivors
Article Title: The growing need for heart failure specific risk prediction models and standardized care pathways in patients with cancer
Article References: Agdamag, A. C., & Tang, W. (2026). The growing need for heart failure specific risk prediction models and standardized care pathways in patients with cancer. Cardio-Oncology, 12(1), Article 109. https://doi.org/10.1186/s40959-026-00563-2
Image Credits: AI Generated
DOI: 10.1186/s40959-026-00563-2
Keywords: cardio-oncology, cancer survivors, heart failure, HFpEF, risk prediction models, cardiometabolic syndrome, clinical care pathways, cardiovascular disease, growing, need, heart, failure
News Source: Nathaniel Bowman. (November 10, 2026). Cancer Survivors Face Heart Failure Risks Requiring Targeted Prediction Models. Scienmag.



